Concurrent versus sequential radiotherapy and tamoxifen in breast cancer - The CONSET trial is launched.
Munshi
Anusheel
A
Gupta
Deepak
D
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage* / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant / Q000379:methods; D017326:Clinical Trials, Phase III as Topic / Q000379:methods; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007194:India; D008168:Lung / Q000187:drug effects* / Q000528:radiation effects*; D008408:Mastectomy / Q000379:methods; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000209:etiology*; D011788:Quality of Life; D018714:Radiotherapy, Adjuvant / Q000379:methods; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D011795:Surveys and Questionnaires; D016019:Survival Analysis; D013629:Tamoxifen / Q000008:administration & dosage* / Q000009:adverse effects
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen